Intravenous Administration of Tc-HMPAO-Labeled Human Mesenchymal Stem Cells after Stroke: In Vivo Imaging and Biodistribution

Intravenous Administration of Tc-HMPAO-Labeled Human Mesenchymal Stem Cells after Stroke: In Vivo Imaging and Biodistribution

Human mesenchymal stem cells (hMSC) are a promising source for cell therapy after stroke. To deliver these cells, an IV injection appears safer than a local graft. We aimed to assess the whole-body biodistribution of IV-injected 99m Tc-HMPAO-labeled hMSC in normal rats ( n = 9) and following a right...

Full description

Bibliographic Details
Main Authors: Olivier Detante, Anaïck Moisan, Julien Dimastromatteo, Marie-Jeanne Richard, Laurent Riou, Emmanuelle Grillon, Emmanuel Barbier, Marie-Dominique Desruet, Florence De Fraipont, Christoph Segebarth, Assia Jaillard, Marc Hommel, Catherine Ghezzi, Chantal Remy
Format: Article
Language:English
Published: SAGE Publishing 2009-12-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368909X474230

Internet

https://doi.org/10.3727/096368909X474230

Similar Items